Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|December 1, 2014
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptorsYeon Sun Lee, Sara M Hall, Cyf Ramos-Colon, et al.BMC Endocrine Disorders|July 7, 2026
Participants' experiences of living with cystic fibrosis related diabetes and using a hybrid closed-loop system to support self-management: qualitative studyJulia Lawton, Amanda I Adler, Amanda Brennan, et al.Diabetes Technology & Therapeutics|February 6, 2019
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative StudyJulia Lawton, Maxine Blackburn, David Rankin, et al.Chemical Biology & Drug Design|May 21, 2016
Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptorsYeon Sun Lee, Robert Kupp, Michael V Remesic, et al.Bioorganic & Medicinal Chemistry|September 20, 2011
Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligandsRuben Vardanyan, Vlad K Kumirov, Gary S Nichol, et al.Bioorganic & Medicinal Chemistry|August 25, 2015
Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligandsSrinivas Deekonda, Lauren Wugalter, Vinod Kulkarni, et al.Bioorganic & Medicinal Chemistry Letters|November 28, 2015
Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluationsSrinivas Deekonda, Jacob Cole, Sydney Sunna, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2015
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivativesSrinivas Deekonda, Lauren Wugalter, David Rankin, et al.Diabetes Technology & Therapeutics|October 5, 2023
Listening to Women: Experiences of Using Closed-Loop in Type 1 Diabetes PregnancyJulia Lawton, Barbara Kimbell, Mia Closs, et al.Diabetes Technology & Therapeutics|February 13, 2020
What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) TrialBarbara Kimbell, David Rankin, Nicole L Ashcroft, et al.Pageof 9